1 year return (CAGR)
23360.74%
Aktis Oncology, Inc. Common stock Exchange (NASDAQ, USD)
AKTS
22.71
+0.30 (+1.34%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
68.46%
5 year return (CAGR)
21.24%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.22B
Price/Sales
143.92
Ent value
1.21B
Price/Book
2.52
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 22.48 |
| Daily high | 22.94 |
| Daily low | 21.31 |
| Daily Volume | 854K |
| All-time high | 32.23 |
| 1y analyst estimate | 34.81 |
| Beta | - |
| EPS (TTM) | -1.04 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| AKTS | S&P500 | |
| Current price drop from All-time high | -29.54% | -3.06% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 18 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -54.26% | -10.68% |
| Avg time to new high | 63 days | 12 days |
| Max time to new high | 974 days | 1805 days |
News
